Establishment of a new classification system for chronic inflammatory demyelinating polyneuropathy based on unsupervised machine learning.
Muscle Nerve. 2022 Nov;66(5):603-611. doi: 10.1002/mus.27702. Epub 2022 Aug 27. Chun-Wei Chang, Long-Sun Ro*, Rong-Kuo Lyu, Hung-Chou Kuo, Ming-Feng Liao, Yih-Ru Wu, Chiung-Mei Chen, Hong-Shiu Chang, Yi-Ching Weng, Chin-Chang Huang, Kuo-Hsuan Chang*.
Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease. Frontiers in Neurology. 21 January 2020; 10:1388. doi: 10.3389/fneur.2019.01388. Chang CW, Yang SY, Yang CC, Chang CW, Wu YR*.
CCM1 and CCM2 variants in patients with cerebral cavernous malformation in an ethnically Chinese population in Taiwan. Sci Rep. 2019 Aug 27;9(1):12387. doi: 10.1038/s41598-019-48448-y. Chang CW, Hsu PW, Wei KC, Chang CW, Fung HC, Hsih MS, Hsu WC, Ro LS, Chang CN, Wang JJ, Wu YR*, Chen ST*.
Elevated serum levels of endothelin-1 in patients with chronic inflammatory demyelinating polyneuropathy. Clin Chim Acta. 2018 Jan;476:49-53. doi: 10.1016/j.cca.2017.11.008. Epub 2017 Nov 11. Chang CW, Wu HC, Lyu RK, Lo YS, Chen CM, Ro LS, Chang HS, Huang CC, Liao MF, Wu YR, Kuo HC, Chu CC, Weng YC, Wei PT, Lo AL, Chang KH*.